Mr. Donehew continues to serve as a member of the Board of Directors. Mr. Donehew brings over thirty-five years of financial, managerial, and general business experience.
Mr. Donehew served as member of the Company’s Board of Directors since February 2000, as President and Treasurer of the Company since November 2000 and as the Secretary of the Company since December 2005. Since August 2015, Mr. Donehew has served as the Company's Chief Operating Officer. Effective upon completion of the Merger, Mr. Donehew resigned as President, Treasurer and Secretary of the Company, but remains as a member of the Board. On May 2, 2015, Mr. Donehew was appointed as the Company’s Chairman of the Board. Effective December 15, 2016, Mr. Donehew resigned as the Company’s Chairman of the Board.
Since May 2008, Mr. Donehew has been the Chief Financial Officer and a member of the Board of Directors of EndogenX, Inc., a specialty pharmaceutical company. Since July 1996, Mr. Donehew has been the Chief Executive Officer of Donehew Capital, LLC, the general partner of Donehew Fund Limited Partnership, a private investment partnership specializing in the securities market. Since 1983, he has also served as Chief Financial Officer of R.D. Garwood, Inc. and Dogwood Publishing Company, Inc.
The Company initially appointed Mr. Donehew to the Company’s Board of Directors to facilitate the Company’s reverse merger with Golf Rounds.com
BOARD OF DIRECTORS, MEMBER
ROBERT H. DONEHEW